Accès libre

Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient

Lina Savsek

Lina Savsek

Department of Neurology, General Hospital CeljeCelje, Slovenia
Recherchez cet auteur sur
Sciendo|Google Scholar
Savsek, Lina
 et 
Tanja Ros Opaskar

Tanja Ros Opaskar

Unit of Neurology, Institute of Oncology LjubljanaLjubljana, Slovenia
Recherchez cet auteur sur
Sciendo|Google Scholar
Opaskar, Tanja Ros
  
16 févr. 2016
Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Télécharger la couverture
Catégorie d'article: Case Report
Publié en ligne: 16 févr. 2016
Pages: 87 - 93
Reçu: 27 mai 2014
Accepté: 21 août 2014
DOI: https://doi.org/10.1515/raon-2014-0042
Mots clés
© 2016 Radiol Oncol
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Figure 1.

(A) MRI at time of diagnosis demonstrating multiple T2 and (B) fluid attenuated inversion recovery (FLAIR) hyperintense parenchymal lesions, located in both cerebral and cerebellar hemispheres, with mild surrounding edema. (C) On T1 sequences, these lesions were hypointense. (D) After contrast administration, only moderate rim enhancement was seen.
(A) MRI at time of diagnosis demonstrating multiple T2 and (B) fluid attenuated inversion recovery (FLAIR) hyperintense parenchymal lesions, located in both cerebral and cerebellar hemispheres, with mild surrounding edema. (C) On T1 sequences, these lesions were hypointense. (D) After contrast administration, only moderate rim enhancement was seen.

Figure 2.

Full body 18F-FDG PET/CT revealing focal hypometabolism, corresponding to toxoplasma lesions. The largest lesion is seen in the right occipital lobe.
Full body 18F-FDG PET/CT revealing focal hypometabolism, corresponding to toxoplasma lesions. The largest lesion is seen in the right occipital lobe.

Figure 3.

Lesion size and edema reduction after 6 weeks of intensive antibiotic therapy, as demonstrated by (A) fluid attenuated inversion recovery (FLAIR) and (B) T1 sequence.
Lesion size and edema reduction after 6 weeks of intensive antibiotic therapy, as demonstrated by (A) fluid attenuated inversion recovery (FLAIR) and (B) T1 sequence.

Figure 4.

Follow-up MRI after 4 months reveals further reduction of lesion size. (A) T1 sequence + gadolinium, (B) T2 sequence.
Follow-up MRI after 4 months reveals further reduction of lesion size. (A) T1 sequence + gadolinium, (B) T2 sequence.
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Médecine, Médecine clinique, Médecine interne, Hématologie, oncologie, Radiologie
RSS Feed de la revue